NewsAmgen Continues to Seek Full Approval for Lumakras Cancer Drug By InvestLuck October 6, 2023 1 Mins read Amgen Inc. remains committed to obtaining full approval from the Food and Drug Administration (FDA) for its Lumakras cancer drug. This comes… Read more
